These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12538674)

  • 1. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice.
    Chun E; Lee J; Cheong HS; Lee KY
    J Immunol; 2003 Feb; 170(3):1183-90. PubMed ID: 12538674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
    Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
    J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.
    Malmassari S; Lone YC; Zhang M; Transy C; Michel ML
    Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo.
    Hwang YK; Kim NK; Park JM; Lee Ky; Han WK; Kim HI; Cheong HS
    Vaccine; 2002 Nov; 20(31-32):3770-7. PubMed ID: 12399208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
    Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
    J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
    Kemp RA; Ronchese F
    J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.
    Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF
    Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones.
    Schreurs MW; Scholten KB; Kueter EW; Ruizendaal JJ; Meijer CJ; Hooijberg E
    J Immunol; 2003 Sep; 171(6):2912-21. PubMed ID: 12960314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma.
    Ding FX; Wang F; Lu YM; Li K; Wang KH; He XW; Sun SH
    Hepatology; 2009 May; 49(5):1492-502. PubMed ID: 19206147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
    Loirat D; Lemonnier FA; Michel ML
    J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive T cell immunotherapy of human uveal melanoma targeting gp100.
    Sutmuller RP; Schurmans LR; van Duivenvoorde LM; Tine JA; van Der Voort EI; Toes RE; Melief CJ; Jager MJ; Offringa R
    J Immunol; 2000 Dec; 165(12):7308-15. PubMed ID: 11120866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional studies of HLA-A0201 restricted CTL epitopes in the X protein of hepatitis B virus.
    Guo YJ; Zhu Y; Sun SH
    Acta Virol; 2011; 55(2):107-15. PubMed ID: 21692558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes.
    Passoni L; Scardino A; Bertazzoli C; Gallo B; Coluccia AM; Lemonnier FA; Kosmatopoulos K; Gambacorti-Passerini C
    Blood; 2002 Mar; 99(6):2100-6. PubMed ID: 11877285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
    Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H
    Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.
    Li B; Wang Y; Chen J; Wu H; Chen W
    Clin Exp Immunol; 2005 May; 140(2):310-9. PubMed ID: 15807856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
    Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
    Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.